Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Tel Aviv - Delayed Quote ILA

Evogene Ltd. (EVGN.TA)

Compare
505.80
-2.00
(-0.39%)
At close: February 24 at 5:24:25 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILA.
NameTitlePayExercisedYear Born
Mr. Ofer Haviv CPA CEO & President 390k -- 1966
Dr. Brian Ember Chief Executive Officer of AgPlenus Ltd 287k -- 1976
Dr. Elran Hillel Haber M.B.A., Ph.D. Chief Executive Officer of Biomica Ltd 302k -- 1980
Mr. Amit Noam Capt. res. Chief Executive Officer of Lavie Bio Ltd. 136k -- 1982
Mr. Yaron Eldad Chief Financial Officer -- -- 1965
Ms. Liat Foigel Wejgman Vice President of Human Resources -- -- --
Mr. Eyal Ronen Executive Vice President of Business Development -- -- 1972
Mr. Yoash Zohar Chief Executive Officer of Casterra Ag Ltd. -- -- 1967
Dr. Dan Jacob Gelvan Ph.D. Chief Executive Officer of Ag Plenus Ltd. -- -- 1964
Mr. Russ Putland Vice President of Commercial of Lavie Bio Ltd. -- -- --

Evogene Ltd.

13 Gad Feinstein Street
Park Rehovot
Rehovot, 7638517
Israel
972 8 931 1900 https://www.evogene.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
142

Description

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.

Corporate Governance

Evogene Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

March 6, 2025 at 1:30 PM UTC

Evogene Ltd. Earnings Date

Recent Events

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.